0001415889-24-014146.txt : 20240522
0001415889-24-014146.hdr.sgml : 20240522
20240522183248
ACCESSION NUMBER: 0001415889-24-014146
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240520
FILED AS OF DATE: 20240522
DATE AS OF CHANGE: 20240522
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Jiang Wenbin
CENTRAL INDEX KEY: 0001872873
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40632
FILM NUMBER: 24974738
MAIL ADDRESS:
STREET 1: C/O CYTEK BIOSCIENCES, INC.
STREET 2: 46107 LANDING PARKWAY
CITY: FREMONT
STATE: CA
ZIP: 94538
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Cytek Biosciences, Inc.
CENTRAL INDEX KEY: 0001831915
STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826]
ORGANIZATION NAME: 08 Industrial Applications and Services
IRS NUMBER: 472547526
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 47215 LAKEVIEW BOULEVARD
CITY: FREMONT
STATE: CA
ZIP: 94538
BUSINESS PHONE: (877) 922-9835
MAIL ADDRESS:
STREET 1: 47215 LAKEVIEW BOULEVARD
CITY: FREMONT
STATE: CA
ZIP: 94538
FORMER COMPANY:
FORMER CONFORMED NAME: Cytek BioSciences, Inc.
DATE OF NAME CHANGE: 20201110
4
1
form4-05222024_100540.xml
X0508
4
2024-05-20
0001831915
Cytek Biosciences, Inc.
CTKB
0001872873
Jiang Wenbin
C/O CYTEK BIOSCIENCES, INC.
47215 LAKEVIEW BOULEVARD
FREMONT
CA
94538
true
true
false
false
PRESIDENT AND CEO
0
Common Stock
2024-05-20
4
M
0
6758
A
5310669
D
Common Stock
2024-05-20
4
F
0
1601
5.96
D
5309068
D
Common Stock
2024-05-20
4
M
0
7854
A
5316922
D
Common Stock
2024-05-20
4
F
0
1913
5.96
D
5315009
D
Common Stock
2024-05-20
4
M
0
14733
A
5329742
D
Common Stock
2024-05-20
4
F
0
3588
5.96
D
5326154
D
Restricted Stock Units
2024-05-20
4
M
0
6758
0
D
Common Stock
6758
45062
D
Restricted Stock Units
2024-05-20
4
M
0
7854
0
D
Common Stock
7854
133523
D
Restricted Stock Units
2024-05-20
4
M
0
14733
0
D
Common Stock
14733
338873
D
Each Restricted Stock Unit (the "RSU Award") represents a contingent right to receive one share of the Issuer's common stock.
Represents the number of shares withheld by and surrendered to the Issuer on May 20, 2024, to satisfy tax withholding obligations that arose in connection with the vesting of the RSU Award.
The shares subject to the RSU Award shall vest quarterly over four years, with 4/48th of the total shares underlying the RSU Award vesting on May 18, 2022 and 3/48th of the total shares underlying the RSU Award vesting each subsequent quarter thereafter on August 18, November 18, February 18 and May 18.
The shares subject to the RSU Award shall vest over 4 years with 2/48 of the total shares underlying the RSU Award vesting on May 18, 2023 and each May 18 thereafter; 3/48 of the total shares underlying the RSU Award vesting on August 18, 2023 and each August 18 thereafter; 3/48 of the total shares underlying the RSU Award vesting on November 18, 2023 and each November 18 thereafter; and 4/48 of the total shares underlying the RSU Award vesting each March 10, 2024 and each March 10 thereafter, until fully vested.
The shares subject to the RSU Award shall vest over 4 years with 2/48 of the total shares underlying the RSU Award vesting on May 18, 2024 and each May 18 thereafter; 3/48 of the total shares underlying the RSU Award vesting on August 18, 2024 and each August 18 thereafter; 3/48 of the total shares underlying the RSU Award vesting on November 18, 2024 and each November 18 thereafter; and 4/48 of the total shares underlying the RSU Award vesting each March 10, 2025 and each March 10 thereafter.
/s/ Valerie Barnett, Attorney-in-Fact
2024-05-22